I Don t Want To Spend This Much Time On Xarelto Lawsuit. How About You

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical organizations, such as the makers of Xarelto, possess a duty to make sure that their drugs are reasonably secure for use - and failure to accomplish so might be grounds for compensation. Our lawyers are operating tough to get these hurt by the drug the compensation they are entitled to.

While bleeding can be a widespread complication connected with anticoagulants, it has been alleged that Xarelto For Blood Clots is a lot more dangerous than classic blood thinners since no antidote exists to reverse its blood-thinning effects. This implies that, in the event of an emergency, sufferers might be at danger for irreversible bleeding problems, including life-threatening internal and gastrointestinal hemorrhaging.

If you or a loved one particular suffered a severe bleeding occasion right after taking Xarelto, you might have legal recourse. For much more information, make contact with us today to have your case reviewed, cost-free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, pain and suffering and, in instances of death, funeral expenditures. Additionally, they may be seeking punitive damages, that are typically awarded to punish the defendant and deter other businesses from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs inside the lawsuits allege significant and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.

Visit this page for a lot more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.